Madhu M Ouseph

TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML

P. D. Dal Cin, D. Arber, O. Weinberg, 2022, Blood advances.

NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotype.

G. Pinkus, P. Cin, A. Bagg, 2022, Leukemia research.

Ets-2 Propagates IL-6 Trans-Signaling Mediated Osteoclast-Like Changes in Human Rheumatoid Arthritis Synovial Fibroblast

S. Khuder, A. Basit, B. Prasad, 2021, Frontiers in Immunology.

Angioimmunoblastic T‐cell lymphoma presenting with severe plasmacytosis mimicking plasma cell leukemia

P. Simonson, G. Roboz, J. Ruan, 2023, American journal of hematology.

STAT5B mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophilia.

A. Bagg, M. Routbort, Z. Zuo, 2023, Haematologica.